Nrg Oncology
Clinical trials sponsored by Nrg Oncology, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study aims to reduce leg swelling in endometrial cancer surgery Results expected Oct 2026 (estimated)
- New drug combo aims to stop prostate cancer spread after surgery Results expected Nov 2026 (estimated)
- Gene test guides prostate cancer therapy: more or less treatment? Results expected Nov 2026 (estimated)
- Blood test could guide chemo for throat cancer patients Results expected Dec 2026 (estimated)
- New drug aims to ease painful mouth sores for head and neck cancer patients Results expected Jan 2027 (estimated)
-
Can molecular markers decide who needs radiation after meningioma surgery?
Disease control Not yet recruitingThis phase 3 trial compares two standard approaches after surgery for certain meningiomas: radiation therapy versus active surveillance (watchful waiting). It includes people with low clinical risk but high molecular risk tumors, who are randomly assigned to either radiation or s…
Phase 3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Major trial asks: is radiation necessary for Low-Risk breast lesions?
Knowledge-focused Not yet recruitingThis study looks at women with a very early form of breast cancer called DCIS. It uses a special test to find those at low risk of the cancer coming back. The goal is to see if these low-risk women can skip radiation therapy after their lump-removal surgery without a meaningful i…
Phase 3 • Sponsor: NRG Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC